| Balancing the scales: achieving the optimal beta-lactam to beta-lactamase inhibitor ratio with continuous infusion piperacillin/tazobactam against extended spectrum beta … PG Cojutti, MP Pai, T Tonetti, A Siniscalchi, P Viale, F Pea Antimicrobial Agents and Chemotherapy 68 (4), e01404-23, 2024 | | 2024 |
| Comparative Impact of an Optimized PK/PD Target Attainment of Piperacillin-Tazobactam vs. Meropenem on the Trend over Time of SOFA Score and Inflammatory Biomarkers in … M Gatti, M Rinaldi, T Tonetti, A Siniscalchi, P Viale, F Pea Antibiotics 13 (4), 296, 2024 | | 2024 |
| Impact of a multidisciplinary management team on clinical outcome in ICU patients affected by Gram-negative bloodstream infections: a pre-post quasi-experimental study M Rinaldi, M Gatti, T Tonetti, D Nocera, S Ambretti, A Berlingeri, ... Annals of Intensive Care 14 (1), 36, 2024 | 2 | 2024 |
| Successful Versus Failed Transition From Controlled Ventilation to Pressure Support Ventilation in COVID-19 Patients: A Retrospective Cohort Study MP Friz, E Rezoagli, BS Fakhr, G Florio, E Carlesso, R Giudici, C Forlini, ... Critical Care Explorations 6 (2), e1039, 2024 | 1 | 2024 |
| Could an optimized joint Pharmacokinetic/Pharmacodynamic target attainment of continuous infusion Piperacillin-Tazobactam be a Valuable innovative Approach for maximizing the … M Gatti, M Rinaldi, T Tonetti, A Siniscalchi, P Viale, F Pea Antibiotics 12 (12), 1736, 2023 | 5 | 2023 |
| Current knowledge gaps in extracorporeal respiratory support T Tonetti, A Zanella, D Pérez-Torres, G Grasselli, VM Ranieri Intensive Care Medicine Experimental 11 (1), 77, 2023 | 2 | 2023 |
| A descriptive pharmacokinetic/pharmacodynamic analysis of continuous infusion meropenem/vaborbactam in the treatment of critically ill patients with documented KPC-producing … M Gatti, M Rinaldi, P Gaibani, A Siniscalchi, T Tonetti, P Viale, F Pea International journal of antimicrobial agents 62 (5), 106992, 2023 | 2 | 2023 |
| Real-time TDM-based expert clinical pharmacological advice program for attaining aggressive pharmacokinetic/pharmacodynamic target of continuous infusion meropenem in the … M Gatti, M Rinaldi, T Tonetti, A Siniscalchi, P Viale, F Pea Antibiotics 12 (10), 1524, 2023 | 1 | 2023 |
| PaO2/FiO2 ratio measured on room air or during supplemental oxygen predicts 28-day mortality in Covid-19 pneumonia: a large multicenter retrospective study. A Tramontano, ML Nicolardi, P Scarano, A Boscolo, R Dongilli, DL Grieco, ... European Respiratory Journal 62 (suppl 67), 2023 | | 2023 |
| Impact of a newly established expert clinical pharmacological advice programme based on therapeutic drug monitoring results in tailoring antimicrobial therapy hospital-wide in … PG Cojutti, M Gatti, F Bonifazi, F Caramelli, A Castelli, M Cavo, M Cescon, ... International Journal of Antimicrobial Agents 62 (2), 106884, 2023 | 4 | 2023 |
| Pharmacokinetics/pharmacodynamics of cefiderocol administered by continuous infusion in a case series of critically ill patients with carbapenem-resistant Acinetobacter … M Gatti, M Rinaldi, T Tonetti, P Gaibani, A Siniscalchi, P Viale, F Pea International Journal of Antimicrobial Agents 62 (2), 106852, 2023 | 1 | 2023 |
| A descriptive pharmacokinetic/pharmacodynamic analysis of continuous infusion ceftazidime-avibactam for treating DTR gram-negative infections in a case series of critically ill … M Gatti, M Rinaldi, P Gaibani, A Siniscalchi, T Tonetti, M Giannella, ... Journal of Critical Care 76, 154301, 2023 | 8 | 2023 |
| Corrigendum to:“Development and validation of a prediction model for severe respiratory failure in hospitalized patients with SARS-CoV-2 infection: a multicentre cohort study … M Bartoletti, M Giannella, L Scudeller, S Tedeschi, M Rinaldi, L Bussini, ... Clinical Microbiology and Infection 29 (6), 817, 2023 | | 2023 |
| Long-term outcome of COVID-19 patients treated with helmet noninvasive ventilation vs. high-flow nasal oxygen: a randomized trial T Michi, C Mattana, LS Menga, MG Bocci, M Cesarano, T Rosà, ... Journal of Intensive Care 11 (1), 21, 2023 | 1 | 2023 |
| Circulating extracellular particles from severe COVID-19 patients show altered profiling and innate lymphoid cell-modulating ability D Forte, RM Pellegrino, S Trabanelli, T Tonetti, F Ricci, M Cenerenti, ... Frontiers in Immunology 14, 1085610, 2023 | 4 | 2023 |
| Weaning from mechanical ventilation in intensive care units across 50 countries (WEAN SAFE): a multicentre, prospective, observational cohort study T Pham, L Heunks, G Bellani, F Madotto, I Aragao, G Beduneau, ... The Lancet Respiratory Medicine 11 (5), 465-476, 2023 | 70 | 2023 |
| Increased duration and similar outcomes of V‐V ECLS in patients with COVID‐19 ARDS compared to non‐COVID ARDS: Single center experience M Benedetto, G Piccone, M Baiocchi, E Cerchierini, M Adversi, A Rossi, ... Artificial Organs 47 (4), 731-739, 2023 | 2 | 2023 |
| Changes in upper airways microbiota in ventilator-associated pneumonia L Alagna, L Mancabelli, F Magni, L Chatenoud, G Bassi, S Del Bianco, ... Intensive Care Medicine Experimental 11 (1), 17, 2023 | 4 | 2023 |
| Impact of a newly established expert clinical pharmacological advice program based on TDM results in tailoring antimicrobial therapies hospital-wide in a tertiary university … PG Cojutti, M Gatti, F Bonifazi, F Caramelli, A Castelli, M Cavo, M Cescon, ... International Journal of Antimicrobial Agents 2023, 1-20, 2023 | 4 | 2023 |
| Environmental contamination by SARS-CoV-2 during noninvasive ventilation in COVID-19 A Dell’Olio, C Vocale, A Primavera, L Pisani, S Altavilla, G Roncarati, ... Respiratory Care 68 (1), 1-7, 2023 | 6 | 2023 |
Francesca CollinoAzienda Ospedaliera Città della Salute e della Scienza di Torino - Department of Anesthesia and在 unito.it 的电子邮件经过验证
